{"id":6014,"date":"2020-12-22T00:00:00","date_gmt":"2020-12-22T00:00:00","guid":{"rendered":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/2020\/12\/22\/mitral-regurgitation-deaths-up-after-prolonged-decline\/"},"modified":"2020-12-23T18:10:25","modified_gmt":"2020-12-23T18:10:25","slug":"mitral-regurgitation-deaths-up-after-prolonged-decline","status":"publish","type":"post","link":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/2020\/12\/22\/mitral-regurgitation-deaths-up-after-prolonged-decline\/","title":{"rendered":"Mitral Regurgitation Deaths Up After Prolonged Decline"},"content":{"rendered":"<h3>\n<p>After continued decline since 1999, MR mortality in U.S. adults has increased by about 1.5 percent per year since 2012<\/p>\n<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>TUESDAY, Dec. 22, 2020 (HealthDay News) &#8212; Mortality due to mitral regurgitation (MR) in U.S. adults declined at an annual rate of approximately 4 percent from 1999 until 2012 but has since then increased by about 1.5 percent annually, according to a study published in the December issue of <em>Mayo Clinic Proceedings<\/em>.<\/p>\n<p>Vibhu Parcha, M.D., from the University of Alabama at Birmingham, and colleagues assessed trends in mortality due to MR using the U.S. Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research database that included nationwide death certificates (1999 through 2018).<\/p>\n<p>The researchers found 45,982 deaths due to MR during the study period, with higher mortality rates seen in older White females from the Western United States. The crude and age-adjusted mortality rates in 1999 were 27.4 and 27.5 per 1 million persons, respectively, which declined by 2018 to 18 and 17.7 per 1 million persons, respectively. From 1999 to 2012, crude mortality rates declined (annual percentage change [APC], \u00e2\u0088\u00924.1; 95 percent confidence interval [CI], \u00e2\u0088\u00924.6 to \u00e2\u0088\u00923.6) but then increased after 2012 (APC, 2.6; 95 percent CI, 0.8 to 4.4; P < 0.001 for change in trend). Similarly, from 1999 to 2012, the age-adjusted mortality rates declined (APC, \u00e2\u0088\u00923.9; 95 percent CI, \u00e2\u0088\u00924.4 to \u00e2\u0088\u00923.4) but subsequently increased after 2012 (APC, 1.4; 95 percent CI, \u00e2\u0088\u00920.4 to 3.2; P < 0.001 for change in trend). Across age, sex, race, geographic region, and urbanization subgroups, the decrease was consistent (P < 0.05 for all).<\/p>\n<p>&#8220;There may be distinct explanations for the increasing mortality rates in the last six years of the study (2012 to 2018), with an annual increase of approximately 1.5 percent,&#8221; the authors write.<\/p>\n<p><a href=\"https:\/\/www.mayoclinicproceedings.org\/article\/S0025-6196(20)30990-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2020 <a href=\"http:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener noreferrer\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>After continued decline since 1999, MR mortality in U.S. adults has increased by about 1.5 percent per year since 2012<\/p>\n","protected":false},"author":4,"featured_media":6165,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[85],"tags":[137,91],"acf":[],"_links":{"self":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts\/6014"}],"collection":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/comments?post=6014"}],"version-history":[{"count":0,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts\/6014\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/media\/6165"}],"wp:attachment":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/media?parent=6014"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/categories?post=6014"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/tags?post=6014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}